COMPANY PROFILE / #3438
Cx Precision Medicine
Fort Worth, TXVenture Capital-Backed
OVERVIEW
Developer of blood-based diagnostic tests designed to rule out neurodegenerative diseases in primary care settings. The company's platform analyzes proteins in blood through artificial intelligence algorithms trained on large sample sets to differentiate patients whose early memory or movement symptoms are unlikely to be caused by Alzheimer's Dementia or Parkinson's Disease, enabling primary care physicians to make more precise referral and treatment decisions.
已融资9.67
最新估值34.00
员工数6
成立年份2016
公司概况
- Companies
- Cx Precision Medicine
- Description
- Developer of blood-based diagnostic tests designed to rule out neurodegenerative diseases in primary care settings. The company's platform analyzes proteins in blood through artificial intelligence algorithms trained on large sample sets to differentiate patients whose early memory or movement symptoms are unlikely to be caused by Alzheimer's Dementia or Parkinson's Disease, enabling primary care physicians to make more precise referral and treatment decisions.
- Website
- www.cxprecisionm.com
- HQ Location
- Fort Worth, TX
- Year Founded
- 2016
- Keywords
- alzheimer's diagnostic guidance, biomarker screening, blood diagnostics, clinical trials support, dementia care, neurodegenerative disease therapy, parkinson's disease, small molecule
- Competitors
- C2N Diagnostics
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 9.67
- First Financing Date
- —
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- 23-May-2024
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 4.00
- Last Financing Valuation
- 34.00
- Last Financing Status
- Completed
- Last Known Valuation
- 34.00
- Last Known Valuation Date
- 23-May-2024
- Last Known Valuation Deal Type
- Later Stage VC
- Valuation Estimate
- 45.33
- Valuation Estimate Growth Rate
- 33.32%
- Active Investors
- Hi2 Global, HSC Next, Ignite Healthcare Network, Springboard Enterprises, TechFW
- # Active Investors
- 5
- Acquirers
- —
团队与联系人
- Employees
- 6
- Employee Growth %
- 20.00% E
- Employee History
- 2026: 6, 2025: 5 E, 2024: 4 E, 2023: 3, 2022: 3 E, 2021: 3 E, 2020: 3 E, 2019: 4 E, 2018: 4 E, 2017: 4 E, 2016: 4
- Primary Contact
- Sid O'Bryant
- Primary Contact Title
- Scientific Founder & Advisory Board Chair
- Primary Contact Email
- sobryant@cxprecisionm.com
- Primary Contact Phone
- +1 (817) 523-1301
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- 0.00%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 13
- Size Multiple
- 0.75x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 37
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- —
- SimilarWeb Unique Visitors Change
- —
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- —
- Success Probability Over Time – 3 Year
- —
- Success Probability Over Time – 5 Year
- —
记录来源：public.companies · 原始序号 #3438 · 所有字段均按数据库原值展示。